Summary by Moomoo AI
KEYSTONE PHARMACEUTICALS ANNOUNCED THAT, PURSUANT TO SECTION 2.07 OF THE SECURITIES LISTING RULES OF HONG KONG UNITED EXCHANGE LIMITED, FROM 31 DECEMBER 2023, THE COMPANY'S COMMUNICATIONS WILL BE PUBLISHED IN FULL ELECTRONIC FORMAT, INCLUDING DIRECTORS' REPORTS, ANNUAL ACCOUNTS, AUDIT REPORTS, INTERIM REPORTS, NOTICE OF MEETINGS, ETC. The Company has provided English and Chinese versions of relevant communications on its official website and on its Disclosure website, replacing traditional printed copies. To ensure timely receipt of communications by shareholders, the Company recommends that shareholders provide an e-mail address and return the accompanying return on or before February 20, 2024. Failure to provide by the shareholder will be deemed to have agreed to receive communications via the Website, but the company's communications available for action will be mailed in printed form. Shareholders may also choose to receive only printed corporate newsletters. The Company emphasises that a valid email address is essential to the exercise of shareholders' rights and provides relevant response forms and contact information for shareholders to update their information.